Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of StemRIM
No Price
Closing Price XTKS 28.04.2026:
301,00 JPY
28.04.2026 06:30
Current Prices from StemRIM
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
4599.T
JPY
28.04.2026 06:30
301,00 JPY
1,00 JPY
+0,33 %
Share Float & Liquidity
Free Float42,22 %
Shares Float26,46 M
Shares Outstanding62,68 M
Company Profile for StemRIM Share
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.
